TD Asset Management’s Maravai LifeSciences MRVI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $156K | Buy |
+64,658
| New | +$156K | ﹤0.01% | 1180 |
|
|
2022
Q4 | – | Sell |
-25,155
| Closed | -$639K | – | 1475 |
|
|
2022
Q3 | $639K | Sell |
25,155
-22,900
| -48% | -$582K | ﹤0.01% | 1252 |
|
|
2022
Q2 | $1.37M | Sell |
48,055
-33,400
| -41% | -$949K | ﹤0.01% | 1119 |
|
|
2022
Q1 | $2.87M | Hold |
81,455
| – | – | ﹤0.01% | 982 |
|
|
2021
Q4 | $3.41M | Hold |
81,455
| – | – | ﹤0.01% | 983 |
|
|
2021
Q3 | $4M | Buy |
81,455
+22,500
| +38% | +$1.1M | ﹤0.01% | 875 |
|
|
2021
Q2 | $2.59M | Buy |
58,955
+34,979
| +146% | +$1.54M | ﹤0.01% | 1022 |
|
|
2021
Q1 | $855K | Buy |
+23,976
| New | +$855K | ﹤0.01% | 1299 |
|